Hansa Biopharma is a biopharmaceutical company developing novel immunomodulatory enzymes for transplantation and acute autoimmune diseases. The lead projet imlifidase (IdeS) is a proprietary antibody-degrading enzyme currently in late-stage clinical development for kidney transplant patients with significant potential for further development in other solid organ transplants and a wide range of acute autoimmune indications.
Workplace & Culture
We are based in Lund, Sweden, and we pride ourselves on providing a supportive team structure and offering numerous opportunities for staff from different departments to work together, sharing knowledge and learning from each other.
Our future as a dynamic organisation is largely dependent on the knowledge, creativity and skills of our employees. We have an informal and flexible work environment, providing numerous opportunities for professional and personal development.
